Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Clinical trial NCT00274144 · COMPLETED

Trial details

NCT number: NCT00274144
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Coronary Arteriosclerosis

Start date: 2001-12-01
Primary completion: 2004-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.